Annual report pursuant to Section 13 and 15(d)

Acquisitions, Investments, and Licenses - Equity Method Investments Narrative (Details)

v3.6.0.2
Acquisitions, Investments, and Licenses - Equity Method Investments Narrative (Details)
$ in Millions
12 Months Ended
Dec. 31, 2016
USD ($)
Schedule of Equity Method Investments [Line Items]  
Total assets of equity method investees $ 430.9
Total liabilities of equity method investees 205.1
Net losses of equity method investees (208.1)
Market value of equity method investees $ 80.1
Pharmsynthez  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 17.00%
Levon Resources Ltd  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 15.00%
InCellDx, Inc  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 27.00%
Neovasc  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 4.00%
Cocrystal Pharma  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 8.00%
Sevion  
Schedule of Equity Method Investments [Line Items]  
Ownership percentage 3.00%